Alpine Immune Sciences Inc expected to post earnings of 1 cents a share - Earnings Preview

Alpine Immune Sciences

08/11/2021 11:29

* Alpine Immune Sciences Inc  ALPN.OQ   ALPN.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 10 (estimated). 
* The Seattle, Washington-based company is expected to report  a
1,007.6% increase in revenue to $21.188 million from $1.91
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Alpine Immune Sciences
Inc is for earnings of 1 cents per share. For the same quarter
last year, the company reported a loss of 28 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Alpine Immune
Sciences Inc is $21​, about 38.7% above​ its last closing price
of $12.88. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.37       -0.40      -0.46     Missed  -16.2
 Mar. 31 2021  -0.36       -0.36      -0.45     Missed  -26.2
 Dec. 31 2020  -0.26       -0.31      -0.27     Beat    13.4​
 Sep. 30 2020  -0.22       -0.23      -0.28     Missed  -20.4
 ​​Jun.        0.04        0.54       -0.53     Missed  -199.1
 30 2020                                                
 Mar. 31 2020  -0.48       -0.47      -0.30     Beat    36.2​
 Dec. 31 2019              -0.58      -0.33     Beat    43.6
 Sep. 30 2019  -0.69       -0.68      -0.62     Beat    8.8
 This summary was machine generated November 8 at 11:29 GMT.  All
figures in US dollars unless otherwise stated